Moscow : Ksenia Shakalova, Vietnam’s VABIOTECH pharmaceutical company, that is expected to bottle Russia’s Sputnik V can turn the Southeast Asian nation into a production center for the COVID-19 vaccine in the region, Vietnamese Ambassador to Russia Dang Minh Khoi said in an interview with Sputnik.
Vietnam registered Sputnik V in March. VABIOTECH received the developer’s certificate of validation and bottled the first batch of the vaccine in July.
“The fact that VABIOTECH has successfully bottled the Sputnik V vaccine is of great significance. In Vietnam, Sputnik V is the only vaccine that has had initial success in technology transfer. Thereby, creating a premise for not only ensuring the domestic demand for vaccines, but also gradually turning Vietnam into a production center for the Sputnik V vaccine in Southeast Asia,” Khoi said.

More Stories
Puri BRICS Disaster Risk Reduction Meeting Opens; Odisha CM Calls for Stronger Global Cooperation
India–U.S. Agricultural Cooperation Gains New Momentum Through Key Dialogue Led by IFFCO Chairman Dileep Sanghani
Bear enters Primary Health Center premises, Video goes on viral